Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMDW) Gains from Sales and Divestitures (2022 - 2025)

OneMedNet (ONMDW) reported Gains from Sales and Divestitures of $1.2 million for Q4 2025, up 519.54% year-over-year from $200000.0 in Q4 2024, and up 519.54% on a QoQ basis from $200000.0 in Q4 2024.

OneMedNet (ONMDW) has 4 years of Gains from Sales and Divestitures data on file, last reported at $1.2 million in Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 519.54% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (up 519.54% YoY) and the FY2025 annual result came in at $1.2 million, up 519.54% from the prior year.
  • Gains from Sales and Divestitures rose to $1.2 million in Q4 2025 per ONMDW's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $177.3 million in Q4 2022 and bottomed at $200000.0 in Q4 2024.
  • The 4-year median for Gains from Sales and Divestitures is $752496.0 (2023), against an average of $44.7 million.
  • The widest annual swing landed in 2023, when Gains from Sales and Divestitures sank 99.85%; it then soared 519.54% in 2025.
  • Tracing ONMDW's Gains from Sales and Divestitures over 4 years: stood at $177.3 million in 2022, then slumped by 99.85% to $265914.0 in 2023, then declined by 24.79% to $200000.0 in 2024, then soared by 519.54% to $1.2 million in 2025.
  • Per Business Quant, the three latest ONMDW Gains from Sales and Divestitures figures stand at $1.2 million (Q4 2025), $200000.0 (Q4 2024), and $265914.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 OneMedNet - - -380,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.24 Mn
Dec 31, 2025 1.24 Mn
Dec 31, 2024 200,000.00
Dec 31, 2024 200,000.00
Dec 31, 2023 265,914.00
Dec 31, 2023 265,914.00
Dec 31, 2022 177.28 Mn
Dec 31, 2022 177.28 Mn